Bolus recombinant urokinase versus heparin in deep venous thrombosis: A randomized controlled trial
- 30 August 1996
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 132 (2) , 314-318
- https://doi.org/10.1016/s0002-8703(96)90427-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosisThe American Journal of Cardiology, 1994
- The Potential Role of Thrombolytic Therapy in Venous ThrombosisArchives of internal medicine (1960), 1992
- Prolonged bleeding time as a marker of venous clot lysis during streptokinase therapyAmerican Heart Journal, 1991
- A Standard Heparin Nomogram for the Management of Heparin TherapyArchives of internal medicine (1960), 1991
- Streptokinase therapy for deep vein thrombosis: A comprehensive review of the english literatureThe American Journal of Medicine, 1990
- Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosisThe American Journal of Medicine, 1990
- How to Select Patients with Deep Vein Thrombosis for tPA TherapyChest, 1989
- Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosisThe American Journal of Medicine, 1984
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957